vs
Extra Space Storage（EXR）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Extra Space Storage的季度营收约是Revvity的1.1倍（$856.0M vs $772.1M），Extra Space Storage净利率更高（28.2% vs 12.7%，领先15.4%），Revvity同比增速更快（5.9% vs 4.4%），过去两年Revvity的营收复合增速更高（9.0% vs 2.8%）
Extra Space Storage是总部位于美国犹他州卡顿伍德高地的房地产投资信托基金，主营自助仓储设施投资运营。旗下运营多个仓储品牌，提供温控仓、可驶入单元、储物柜、船只/房车/企业仓储等服务，截至2024年3月，在全美43个州及华盛顿特区共运营3714处网点。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
EXR vs RVTY — 直观对比
营收规模更大
EXR
是对方的1.1倍
$772.1M
营收增速更快
RVTY
高出1.5%
4.4%
净利率更高
EXR
高出15.4%
12.7%
两年增速更快
RVTY
近两年复合增速
2.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $856.0M | $772.1M |
| 净利润 | $241.0M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 42.9% | 14.5% |
| 净利率 | 28.2% | 12.7% |
| 营收同比 | 4.4% | 5.9% |
| 净利润同比 | -11.4% | 3.9% |
| 每股收益（稀释后） | $1.14 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXRRVTY
| Q1 26 | $856.0M | — | ||
| Q4 25 | $857.5M | $772.1M | ||
| Q3 25 | $858.5M | $698.9M | ||
| Q2 25 | $841.6M | $720.3M | ||
| Q1 25 | $820.0M | $664.8M | ||
| Q4 24 | $821.9M | $729.4M | ||
| Q3 24 | $824.8M | $684.0M | ||
| Q2 24 | $810.7M | $691.7M |
净利润EXRRVTY
| Q1 26 | $241.0M | — | ||
| Q4 25 | $287.4M | $98.4M | ||
| Q3 25 | $166.0M | $46.7M | ||
| Q2 25 | $249.7M | $53.9M | ||
| Q1 25 | $270.9M | $42.2M | ||
| Q4 24 | $262.5M | $94.6M | ||
| Q3 24 | $193.2M | $94.4M | ||
| Q2 24 | $185.9M | $55.4M |
毛利率EXRRVTY
| Q1 26 | — | — | ||
| Q4 25 | 73.0% | — | ||
| Q3 25 | 72.6% | 53.6% | ||
| Q2 25 | 73.0% | 54.5% | ||
| Q1 25 | 72.7% | 56.5% | ||
| Q4 24 | 73.1% | — | ||
| Q3 24 | 74.7% | 56.3% | ||
| Q2 24 | 75.7% | 55.7% |
营业利润率EXRRVTY
| Q1 26 | 42.9% | — | ||
| Q4 25 | 43.3% | 14.5% | ||
| Q3 25 | 32.5% | 11.7% | ||
| Q2 25 | 44.4% | 12.6% | ||
| Q1 25 | 47.4% | 10.9% | ||
| Q4 24 | 46.2% | 16.3% | ||
| Q3 24 | 36.7% | 14.3% | ||
| Q2 24 | 37.6% | 12.4% |
净利率EXRRVTY
| Q1 26 | 28.2% | — | ||
| Q4 25 | 33.5% | 12.7% | ||
| Q3 25 | 19.3% | 6.7% | ||
| Q2 25 | 29.7% | 7.5% | ||
| Q1 25 | 33.0% | 6.4% | ||
| Q4 24 | 31.9% | 13.0% | ||
| Q3 24 | 23.4% | 13.8% | ||
| Q2 24 | 22.9% | 8.0% |
每股收益（稀释后）EXRRVTY
| Q1 26 | $1.14 | — | ||
| Q4 25 | $1.35 | $0.86 | ||
| Q3 25 | $0.78 | $0.40 | ||
| Q2 25 | $1.18 | $0.46 | ||
| Q1 25 | $1.28 | $0.35 | ||
| Q4 24 | $1.23 | $0.77 | ||
| Q3 24 | $0.91 | $0.77 | ||
| Q2 24 | $0.88 | $0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $139.0M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $7.3B |
| 总资产 | $29.1B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EXRRVTY
| Q1 26 | $139.0M | — | ||
| Q4 25 | $138.9M | $919.9M | ||
| Q3 25 | $111.9M | $931.4M | ||
| Q2 25 | $125.0M | $991.8M | ||
| Q1 25 | $119.6M | $1.1B | ||
| Q4 24 | $138.2M | $1.2B | ||
| Q3 24 | $88.9M | $1.2B | ||
| Q2 24 | $77.0M | $2.0B |
股东权益EXRRVTY
| Q1 26 | — | — | ||
| Q4 25 | $13.4B | $7.3B | ||
| Q3 25 | $13.6B | $7.4B | ||
| Q2 25 | $13.8B | $7.6B | ||
| Q1 25 | $13.9B | $7.6B | ||
| Q4 24 | $13.9B | $7.7B | ||
| Q3 24 | $14.0B | $7.9B | ||
| Q2 24 | $14.2B | $7.9B |
总资产EXRRVTY
| Q1 26 | $29.1B | — | ||
| Q4 25 | $29.3B | $12.2B | ||
| Q3 25 | $29.2B | $12.1B | ||
| Q2 25 | $29.4B | $12.4B | ||
| Q1 25 | $29.0B | $12.4B | ||
| Q4 24 | $28.8B | $12.4B | ||
| Q3 24 | $28.1B | $12.8B | ||
| Q2 24 | $27.8B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流EXRRVTY
| Q1 26 | — | — | ||
| Q4 25 | $1.9B | $182.0M | ||
| Q3 25 | $457.1M | $138.5M | ||
| Q2 25 | $543.9M | $134.3M | ||
| Q1 25 | $481.4M | $128.2M | ||
| Q4 24 | $1.9B | $174.2M | ||
| Q3 24 | $468.4M | $147.9M | ||
| Q2 24 | $545.2M | $158.6M |
自由现金流EXRRVTY
| Q1 26 | — | — | ||
| Q4 25 | $1.6B | $161.8M | ||
| Q3 25 | $444.2M | $120.0M | ||
| Q2 25 | $382.1M | $115.5M | ||
| Q1 25 | $345.4M | $112.2M | ||
| Q4 24 | $1.6B | $149.8M | ||
| Q3 24 | $310.1M | $125.6M | ||
| Q2 24 | $517.6M | $136.6M |
自由现金流率EXRRVTY
| Q1 26 | — | — | ||
| Q4 25 | 186.5% | 21.0% | ||
| Q3 25 | 51.7% | 17.2% | ||
| Q2 25 | 45.4% | 16.0% | ||
| Q1 25 | 42.1% | 16.9% | ||
| Q4 24 | 198.2% | 20.5% | ||
| Q3 24 | 37.6% | 18.4% | ||
| Q2 24 | 63.8% | 19.7% |
资本支出强度EXRRVTY
| Q1 26 | — | — | ||
| Q4 25 | 29.3% | 2.6% | ||
| Q3 25 | 1.5% | 2.6% | ||
| Q2 25 | 19.2% | 2.6% | ||
| Q1 25 | 16.6% | 2.4% | ||
| Q4 24 | 31.4% | 3.4% | ||
| Q3 24 | 19.2% | 3.3% | ||
| Q2 24 | 3.4% | 3.2% |
现金转化率EXRRVTY
| Q1 26 | — | — | ||
| Q4 25 | 6.44× | 1.85× | ||
| Q3 25 | 2.75× | 2.97× | ||
| Q2 25 | 2.18× | 2.49× | ||
| Q1 25 | 1.78× | 3.03× | ||
| Q4 24 | 7.19× | 1.84× | ||
| Q3 24 | 2.42× | 1.57× | ||
| Q2 24 | 2.93× | 2.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXR
| Property rental | $733.2M | 86% |
| Tenant reinsurance | $89.1M | 10% |
| Management fees and other income | $33.7M | 4% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
